Literature DB >> 31776629

Striking neurologic 18F-FDG PET/CT pattern in Devic's disease (neuromyelitis optica spectrum disorder).

Diego Alfonso López-Mora1, Albert Flotats2, Alejandro Fernández2, Marina Sizova2, Valle Camacho2, Ignasi Carrió2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31776629     DOI： 10.1007/s00259-019-04549-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder.

Authors:  Akira Higashiyama; Tsuyoshi Komori; Yuki Inada; Mitsuo Nishizawa; Hideto Nakajima; Yoshifumi Narumi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-01       Impact factor: 9.236

Review 2.  Neuromyelitis Optica.

Authors:  Sarah L Patterson; Sarah E Goglin
Journal:  Rheum Dis Clin North Am       Date:  2017-08-31       Impact factor: 2.670

3.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 4.  Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes.

Authors:  Marco A Lana-Peixoto; Natália Talim
Journal:  Biomedicines       Date:  2019-06-12
  4 in total
  2 in total

Review 1.  Update on neuromyelitis optica spectrum disorder.

Authors:  Kathryn B Holroyd; Giovanna S Manzano; Michael Levy
Journal:  Curr Opin Ophthalmol       Date:  2020-11       Impact factor: 4.299

Review 2.  PET imaging of reactive astrocytes in neurological disorders.

Authors:  Yu Liu; Han Jiang; Xiyi Qin; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-07       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.